Narin Ahmed
About Narin Ahmed
Narin Ahmed is the Vice President of Regulatory Science at Tessera Therapeutics, where he has worked since 2023. He has over a decade of experience in regulatory affairs, particularly in cell and gene therapy, and has played a key role in the approval of CAR T cell therapies.
Work at Tessera Therapeutics
Narin Ahmed currently serves as Vice President of Regulatory Science at Tessera Therapeutics. He has held this position since 2023, contributing to the company's regulatory strategies and compliance efforts. His role involves overseeing regulatory submissions and ensuring that the company's innovative therapies meet the necessary regulatory requirements.
Previous Experience in Regulatory Affairs
Before joining Tessera Therapeutics, Narin Ahmed worked at GentiBio as Vice President and Head of Regulatory Affairs from 2021 to 2023. His previous roles include Senior Director at Bristol Myers Squibb, where he led global regulatory efforts for CAR T therapies, and various positions at Novartis, focusing on CAR-T products. His extensive background in regulatory affairs spans over a decade, particularly in cell and gene therapy.
Education and Expertise
Narin Ahmed holds a PharmD from Temple University, which he completed from 2006 to 2010. He further advanced his education at Rutgers University, where he achieved a PharmD Fellowship in Drug Regulatory Affairs from 2010 to 2012. Additionally, he earned a Bachelor of Science in Biopharmaceutical Science with a focus on Genomics from the University of Ottawa from 2002 to 2006. His educational background supports his expertise in regulatory science.
Achievements in CAR T Cell Therapy Approvals
Narin Ahmed played a significant role in the regulatory approval processes for two CAR T cell therapies: Kymriah and Abecma. He served as the Global Regulatory Lead for Abecma's approval and was the US Regulatory Co-Lead for Kymriah. His contributions have been pivotal in advancing these therapies, which are critical in the treatment of certain cancers.
Academic Involvement
Narin Ahmed has also contributed to academia as an Adjunct Faculty member at Rutgers University from 2010 to 2011. His experience in teaching complements his professional background in regulatory affairs, allowing him to share his knowledge and expertise with students in the field.